基因多态性与骨性关节炎的研究进展

ISSN:2705-098X(P)

EISSN:2705-0505(O)

语言:中文

作者
邢贺威,吴 焘
文章摘要
骨性关节炎(OA)是一种慢性退行性疾病,其主要特征为关节软骨的退化和关节周围组织的重塑。虽然OA的发病机制复杂且涉及多种因素,但近年来的研究表明,遗传因素,尤其是基因多态性,在OA的易感性和进展中起着关键作用。通过对候选基因和全基因组关联研究(GWAS)的广泛分析,研究者已识别出多个与OA相关的基因位点,如COL2A1、MMP、ACAN、IL-1家族基因、TNF-α和GDF5等。这些基因多态性与OA的核心病理过程密切相关,包括软骨代谢、炎症反应和骨密度变化。本文综述了近年来基因多态性在OA研究领域的最新进展。
文章关键词
基因多态性;骨性关节炎;慢性退行性疾病;遗传因素
参考文献
[1] 廖德发.我国骨性关节炎流行病学调查现状[J].微创医学,2017,12(04):521-4. [2] Tschon M,Contartese D,Pagani S,et al.Gender and sex are key determinants in osteoarthritis not only confounding variables.A systematic review of clinical data[J].Journal of clinical medicine,2021,10(14):3178. [3] Ge Y,Chen Z,Fu Y,et al.Identification and validation of hub genes of synovial tissue for patients with osteoarthritis and rheumatoid arthritis[J].Hereditas,2021,158:1-16. [4] Bielajew B J,Hu J C,Athanasiou K A.Collagen:quantification,biomechanics and role of minor subtypes in cartilage[J].Nature Reviews Materials,2020,5(10):730-47. [5] 张铂彦,张悦,刘贺,et al.COL2A1基因突变与Ⅱ型胶原蛋白病表型关系的研究进展[J].吉林大学学报:医学版,2020,46(3):643-8. [6] Blain E J.Involvement of the cytoskeletal elements in articular cartilage homeostasis and pathology[J].International journal of experimental pathology,2009,90(1):1-15. [7] Madry H,Cucchiarini M.Gene therapy for human osteoarthritis:principles and clinical translation[J].Expert opinion on biological therapy,2016,16(3):331-46. [8] 郭文,高斌礼,杨勇,et al.基质金属蛋白酶3基因多态性与膝骨性关节炎的遗传易感性[J].中国组织工程研究,2022,26(12):1894-8. [9] Mitchell P G,Magna H A,Reeves L M,et al.Cloning,expression,and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage[J].The Journal of clinical investigation,1996,97(3):761-8. [10] Hu Q,Ecker M.Overview of MMP-13 as a promising target for the treatment of osteoarthritis[J].International journal of molecular sciences,2021,22(4):1742. [11] Reynard L N,Loughlin J.The genetics and functional analysis of primary osteoarthritis susceptibility[J].Expert reviews in molecular medicine,2013,15:e2. [12] Mehta S,Akhtar S,Porter R M,et al.Interleukin-1 receptor antagonist(IL-1Ra)is more effective in suppressing cytokine-induced catabolism in cartilage-synovium co-culture than in cartilage monoculture[J].Arthritis research&therapy,2019,21:1-15. [13] Ni H,Shi D,Dai J,et al.Genetic polymorphisms of interleukin-1β(−511C/T)and interleukin-1 receptor antagonist(86-bpVNTR)in susceptibility to knee osteoarthritis in a Chinese Han population[J].Rheumatology international,2009,29:1301-5. [14] Arend W P,Malyak M,Guthridge C J,et al.Interleukin-1 receptor antagonist:role in biology[J].Annual review of immunology,1998,16(1):27-55. [15] Chevalier X,Goupille P,Beaulieu A,et al.Intraarticular injection of anakinra in osteoarthritis of the knee:a multicenter, randomized, double-blind,placebo‐controlled study[J].Arthritis Care&Research,2009,61(3):344-52. [16] 鲍亮,赵晨,刘琮,et al.膝关节液和血清肿瘤坏死因子与IL-1的临床意义[J].中南医学科学杂志,2020,48(05):458-60+64. [17] Han L,Song J H,Yoon J H,et al.TNF-αand TNF-βpolymorphisms are associated with susceptibility to osteoarthritis in a Korean population[J].Korean Journal of Pathology,2012,46(1):30. [18] Wang C-C,Huang C-Y,Lee M-C,et al.Genetic association between TNF-αG-308A and osteoarthritis in Asians:A case–control study and meta-analysis[J].Plos one,2021,16(11):e0259561. [19] Miyamoto Y,Mabuchi A,Shi D,et al.A functional polymorphism in the 5′UTR of GDF5 is associated with susceptibility to osteoarthritis[J].Nature genetics,2007,39(4):529-33.
Full Text:
DOI